ALLENDALE, N.J.--(BUSINESS WIRE)--Stryker’s Spine division will demonstrate its new 3D-printed Tritanium C Anterior Cervical Cage, an interbody fusion device designed for use in the cervical spine, at the Congress of Neurological Surgeons (CNS) Annual Meeting, Oct. 7-11, 2017, in Boston (booth No. 311).
The Tritanium C Anterior Cervical Cage is the latest spinal fusion implant constructed from Stryker’s proprietary Tritanium In-Growth Technology,1 a novel, highly porous titanium material designed for bone in-growth and biological fixation.1
The unique porous structure of Tritanium is created to provide a favorable environment for cell attachment and proliferation, as demonstrated in an in-vitro study.2* The Tritanium material may be able to wick or retain fluid, in comparison to traditional titanium.3 Tritanium is inspired by the microstructure of cancellous bone4 and enabled by AMagine™, Stryker’s proprietary approach to implant creation using additive manufacturing, also known as 3D printing.
“We look forward to showcasing the Tritanium C Anterior Cervical Cage and demonstrating its advanced capabilities at the CNS meeting,” said Bradley Paddock, President of Stryker’s Spine division. “Stryker’s Tritanium Technology is ‘engineered for bone.’ Our growing line of Tritanium implants reflects our commitment to being at the forefront of technology advances in spinal surgery, and to providing our surgeon customers with a range of options to address their preferences and meet the needs of their patients.”
According to Mohammed Faraz Khan, M.D., Hackensack University Medical Center, N.J., one of the first surgeons to use the new cage, the benefits of the Tritanium C Anterior Cervical Cage are clear. “In my opinion, this new addition is going to make all the difference in this space,” Khan said. “The inserter used with the system was super sleek and easy to use.”
The Tritanium C Anterior Cervical Cage received 510(k) clearance from the U.S. Food and Drug Administration in September 2017 and will be available to surgeons in Q4 2017. It features an open central graft window and lateral windows to help reduce stiffness of the cage and minimize subsidence. In addition, the large graft window allows for bone graft containment. Engineered for stability,5 the cage has serrations on the superior and inferior surfaces designed to allow for bidirectional fixation and to maximize surface area for endplate contact with the cage. Its smooth posterior edges help to facilitate insertion and to protect soft tissue and anatomy. The Tritanium C Anterior Cervical Cage is offered in a number of footprints, heights, and lordotic angles to adapt to a variety of patient anatomies.
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
|1.||PROJ43909 Tritanium technology claim support memo|
|2.||RD0000053710: Tritanium cell infiltration and attachment experiment|
|*No correlation to human clinical outcomes has been demonstrated or established|
|3.||RD0000050927: Tritanium material capillary evaluation|
|4.||Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials, 26, 5475-5491|
|5.||PROJ44960: Coefficient of friction memo|
Content ID: TRICC-PR-2_15699
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.